Department of Pharmacy, Lunéville Hospital, France.
Department of Medical Information, University Hospital of Strasbourg, France.
Eur J Intern Med. 2015 Sep;26(7):491-7. doi: 10.1016/j.ejim.2015.07.014. Epub 2015 Jul 21.
Medication reconciliation is a powerful process to correct medication errors (ME) resulting from miscommunicated information at transitions of care. This study aims to develop and evaluate a scoring method for assessing the severity of potential harm of ME intercepted by medication reconciliation at hospital admission in elderly.
The development of the scoring method was based on a literature search and the creation of a list of high-risk drugs used in outpatient care. The evaluation of the method was carried out in 7 French hospitals and was based on two criteria: the inter-rater reliability and acceptability. The assessment of the inter-rater reliability was based on intra-class correlation coefficient (ICC) calculations. Each hospital prospectively enrolled the 10 first patients aged 65 or older presenting with at least one ME. Seven blocks of 10 patients were formed. After randomization, each block was rated by practitioners from 3 hospitals. The assessment of the acceptability was based on a satisfaction questionnaire.
A clinical algorithm was developed. The inter-rater reliability of the method was validated by the overall agreement of the 7 hospitals ratings. The agreement was at least substantial (ICC>0.60) and in most of cases almost perfect (ICC>0.80). The acceptability of the method was judged as satisfactory.
This multi-centre project has validated an instrument for assessing the severity of potential harm of ME intercepted by medication reconciliation. This will allow studies to be conducted with large cohorts of patients in order to develop epidemiological databases of ME of potential clinical significance.
药物重整是一种强大的过程,可以纠正由于医疗保健过渡期间信息沟通不畅而导致的药物错误(ME)。本研究旨在开发和评估一种评分方法,用于评估在老年患者入院时药物重整截获的 ME 的潜在危害严重程度。
评分方法的开发基于文献检索和高风险药物清单的创建,这些药物用于门诊护理。该方法的评估在 7 家法国医院进行,基于两个标准:组内相关系数(ICC)计算的内部一致性和可接受性。评估内部一致性是基于内部一致性系数(ICC)的计算。每家医院前瞻性地招募了 10 名年龄在 65 岁或以上、至少有 1 种 ME 的患者。形成了 7 个 10 名患者的块。随机分组后,每个块由来自 3 家医院的从业者进行评估。可接受性的评估是基于满意度问卷。
开发了一种临床算法。该方法的组内一致性通过 7 家医院的评分总体一致性进行了验证。一致性至少为中等(ICC>0.60),在大多数情况下几乎为完美(ICC>0.80)。该方法的可接受性被认为是令人满意的。
这项多中心项目验证了一种评估药物重整截获的 ME 的潜在危害严重程度的工具。这将允许对大量患者进行研究,以便开发具有潜在临床意义的 ME 的流行病学数据库。